- Home
- Publications
- Publication Search
- Publication Details
Title
Prediction and Prevention of Type 1 Diabetes
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-06-02
DOI
10.3389/fendo.2020.00248
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetics Coming of Age in Type 1 Diabetes
- (2019) Karen Cerolsaletti et al. DIABETES CARE
- Serum 25-Hydroxyvitamin D Concentrations at Birth in Children Screened for HLA-DQB1 Conferred Risk for Type 1 Diabetes
- (2019) Marjaana Mäkinen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Continuous Glucose Monitoring Predicts Progression to Diabetes in Autoantibody Positive Children
- (2019) Andrea K Steck et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies
- (2019) Rocky Strollo et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
- (2019) Michael J. Haller et al. DIABETES
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
- (2019) Anette-Gabriele Ziegler et al. BMJ Open
- Early-life factors contributing to type 1 diabetes
- (2019) Maria E. Craig et al. DIABETOLOGIA
- Vitamin D and ω-3 Supplementations in Mediterranean Diet During the 1st Year of Overt Type 1 Diabetes: A Cohort Study
- (2019) Francesco Cadario et al. Nutrients
- C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase
- (2018) Beverley M. Shields et al. DIABETES CARE
- A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
- (2018) Maria J. Redondo et al. DIABETES CARE
- Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1cin New-Onset Type 1 Diabetes
- (2018) Michael J. Haller et al. DIABETES CARE
- Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predicting progression to diabetes in islet autoantibody positive children
- (2018) Andrea K. Steck et al. JOURNAL OF AUTOIMMUNITY
- Verapamil and beta cell function in adults with recent-onset type 1 diabetes
- (2018) Fernando Ovalle et al. NATURE MEDICINE
- Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics
- (2018) Gordon C Weir et al. PEDIATRIC DIABETES
- Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children
- (2018) Ezio Bonifacio et al. PLOS MEDICINE
- Immune Mechanisms and Pathways Targeted in Type 1 Diabetes
- (2018) Laura M. Jacobsen et al. Current Diabetes Reports
- The human gut microbiome in early-onset type 1 diabetes from the TEDDY study
- (2018) Tommi Vatanen et al. NATURE
- Temporal development of the gut microbiome in early childhood from the TEDDY study
- (2018) Christopher J. Stewart et al. NATURE
- The challenge of modulating β-cell autoimmunity in type 1 diabetes
- (2018) Mark A Atkinson et al. Lancet Diabetes & Endocrinology
- Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes
- (2017) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Modulation of inflammatory and immune responses by vitamin D
- (2017) Francesco Colotta et al. JOURNAL OF AUTOIMMUNITY
- Genetics of type 1 diabetes
- (2017) Maria J Redondo et al. PEDIATRIC DIABETES
- Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
- (2017) Kelen C. R. Malmegrim et al. Frontiers in Immunology
- Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential
- (2017) Wendy Dankers et al. Frontiers in Immunology
- A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes
- (2017) Katherine R. Marino et al. PLoS One
- Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes
- (2016) Michael J. Haller et al. DIABETES
- Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes
- (2016) Kashyap A. Patel et al. DIABETES
- Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial
- (2016) Stephen E. Gitelman et al. DIABETOLOGIA
- Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset
- (2016) Susanne M. Cabrera et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Genetic risk factors for type 1 diabetes
- (2016) Flemming Pociot et al. LANCET
- JDRF's vision and strategy for prevention of type 1 diabetes
- (2016) Richard Insel et al. PEDIATRIC DIABETES
- Vitamin D and autoimmunity
- (2016) Y Rosen et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
- (2015) Richard A. Insel et al. DIABETES CARE
- Predicting Type 1 Diabetes Using Biomarkers
- (2015) Ezio Bonifacio DIABETES CARE
- Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY)
- (2015) Andrea K. Steck et al. DIABETES CARE
- A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults
- (2015) Richard A. Oram et al. DIABETES CARE
- Antibodies to post-translationally modified insulin in type 1 diabetes
- (2015) Rocky Strollo et al. DIABETOLOGIA
- The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study
- (2015) Jeffrey P. Krischer et al. DIABETOLOGIA
- Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 Diabetes
- (2015) Ezio Bonifacio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
- (2015) Michelle Rosenzwajg et al. JOURNAL OF AUTOIMMUNITY
- Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention
- (2015) Aaron Michels et al. PEDIATRIC DIABETES
- Type 1 diabetes immunotherapy using polyclonal regulatory T cells
- (2015) Jeffrey A. Bluestone et al. Science Translational Medicine
- Regulation of Dendritic Cell Function by Vitamin D
- (2015) Myriam Barragan et al. Nutrients
- Reduction in CD4 Central Memory T-Cell Subset in Costimulation Modulator Abatacept-Treated Patients With Recent-Onset Type 1 Diabetes Is Associated With Slower C-Peptide Decline
- (2014) T. Orban et al. DIABETES
- Recognition of Posttranslationally Modified GAD65 Epitopes in Subjects With Type 1 Diabetes
- (2014) J. W. McGinty et al. DIABETES
- Citrullinated Glucose-Regulated Protein 78 Is an Autoantigen in Type 1 Diabetes
- (2014) Dieter Rondas et al. DIABETES
- Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
- (2014) Ronnie Aronson et al. DIABETES CARE
- Role of Viruses and Other Microbes in the Pathogenesis of Type 1 Diabetes
- (2014) Anita Kondrashova et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Hydrolyzed Infant Formula and Early β-Cell Autoimmunity
- (2014) Mikael Knip et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes
- (2014) Michael J. Haller et al. JOURNAL OF CLINICAL INVESTIGATION
- Phases of type 1 diabetes in children and adolescents
- (2014) Jennifer J Couper et al. PEDIATRIC DIABETES
- The effect of childhood cow's milk intake and HLA-DR genotype on risk of islet autoimmunity and type 1 diabetes: The Diabetes Autoimmunity Study in the Young
- (2014) Molly M Lamb et al. PEDIATRIC DIABETES
- Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial
- (2014) Kurt J Griffin et al. Lancet Diabetes & Endocrinology
- A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion
- (2013) Ezio Bonifacio et al. ACTA DIABETOLOGICA
- Major Histocompatibility Complex Genomics and Human Disease
- (2013) John Trowsdale et al. Annual Review of Genomics and Human Genetics
- Posttranslational Modification of HLA-DQ Binding Islet Autoantigens in Type 1 Diabetes
- (2013) M. van Lummel et al. DIABETES
- Patterns of -Cell Autoantibody Appearance and Genetic Associations During the First Years of Life
- (2013) J. Ilonen et al. DIABETES
- Definition of High-Risk Type 1 Diabetes HLA-DR and HLA-DQ Types Using Only Three Single Nucleotide Polymorphisms
- (2013) C. Nguyen et al. DIABETES
- Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes: Two-Year Results From the Randomized, Placebo-Controlled Protege Trial
- (2013) W. Hagopian et al. DIABETES
- Residual -Cell Function 3-6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents
- (2013) J. S. Sorensen et al. DIABETES CARE
- B-Lymphocyte Depletion With Rituximab and -Cell Function: Two-Year Results
- (2013) M. D. Pescovitz et al. DIABETES CARE
- Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study
- (2013) P. Ambery et al. DIABETIC MEDICINE
- The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
- (2013) Richard A. Oram et al. DIABETOLOGIA
- Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
- (2013) Anette G. Ziegler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Antigen-Specific Therapeutic Approaches in Type 1 Diabetes
- (2013) X. Clemente-Casares et al. Cold Spring Harbor Perspectives in Medicine
- Antigen Targets of Type 1 Diabetes Autoimmunity
- (2013) B. O. Roep et al. Cold Spring Harbor Perspectives in Medicine
- Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
- (2013) Mark R Rigby et al. Lancet Diabetes & Endocrinology
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
- (2013) Stephen E Gitelman et al. Lancet Diabetes & Endocrinology
- Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data
- (2012) C. J. Greenbaum et al. DIABETES
- Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population: Receiver operating characteristic analysis
- (2012) P. Xu et al. DIABETES CARE
- Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk
- (2012) V. Parikka et al. DIABETOLOGIA
- Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes
- (2012) A.-G. Ziegler et al. DIABETOLOGIA
- HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus
- (2012) R. Strollo et al. DIABETOLOGIA
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus
- (2010) Douglas O. Sobel et al. ACTA DIABETOLOGICA
- Genetics of Type 1 Diabetes: What's Next?
- (2010) F. Pociot et al. DIABETES
- Enterovirus RNA in Blood Is Linked to the Development of Type 1 Diabetes
- (2010) S. Oikarinen et al. DIABETES
- Prediction of Type 1 Diabetes in the General Population
- (2010) M. Knip et al. DIABETES CARE
- Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
- (2010) B. Keymeulen et al. DIABETOLOGIA
- Prediction and Pathogenesis in Type 1 Diabetes
- (2010) Anette-G. Ziegler et al. IMMUNITY
- Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot randomized, placebo-controlled, double-blind study
- (2009) L. Mastrandrea et al. DIABETES CARE
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rate of β-Cell Destruction in Type 1 Diabetes Influences the Development of Diabetic Retinopathy: Protective Effect of Residual β-Cell Function for More Than 10 Years
- (2008) Koji Nakanishi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started